Which has better valuation and earnings, ANGO or ATRC?

AtriCure has higher revenue and earnings than AngioDynamics. AtriCure is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AngioDynamics $292.50M 1.69 -$33.99M -$0.75 N/A AtriCure $534.53M 2.57 -$11.45M -$0.10 N/A

Is ANGO or ATRC more profitable?

AtriCure has a net margin of -0.83% compared to AngioDynamics' net margin of -10.01%. AtriCure's return on equity of 0.29% beat AngioDynamics' return on equity. Company Net Margins Return on Equity Return on Assets AngioDynamics -10.01% -4.66% -3.08% AtriCure -0.83% 0.29% 0.22%

Is ATEC or ANGO more profitable?

AngioDynamics has a net margin of -10.01% compared to Alphatec's net margin of -15.93%. AngioDynamics' return on equity of -4.66% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Alphatec -15.93% -1,183.84% -15.83% AngioDynamics -10.01% -4.66% -3.08%

AngioDynamics (ANGO) Competitors

$11.94 -0.09 (-0.75%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$11.94 +0.01 (+0.04%)

As of 06/5/2026 07:03 PM Eastern

Compare

ANGO vs. TMO, WST, SMA, ATRC, and ATEC

Should you buy AngioDynamics stock or one of its competitors? MarketBeat compares AngioDynamics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Smartstop Self Storage REIT (SMA), AtriCure (ATRC), and Alphatec (ATEC).

How does AngioDynamics compare to Thermo Fisher Scientific?

AngioDynamics (NASDAQ:ANGO) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 6.0% of AngioDynamics shares are held by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$292.50M	1.69	-$33.99M	-$0.75	N/A
Thermo Fisher Scientific	$44.56B	3.94	$6.70B	$18.19	26.00

Thermo Fisher Scientific has a net margin of 15.15% compared to AngioDynamics' net margin of -10.01%. Thermo Fisher Scientific's return on equity of 16.86% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-10.01%	-4.66%	-3.08%
Thermo Fisher Scientific	15.15%	16.86%	8.15%

In the previous week, Thermo Fisher Scientific had 37 more articles in the media than AngioDynamics. MarketBeat recorded 37 mentions for Thermo Fisher Scientific and 0 mentions for AngioDynamics. Thermo Fisher Scientific's average media sentiment score of 1.28 beat AngioDynamics' score of 0.00 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Overall Sentiment
AngioDynamics	Neutral
Thermo Fisher Scientific	Positive

AngioDynamics presently has a consensus target price of $18.67, indicating a potential upside of 56.34%. Thermo Fisher Scientific has a consensus target price of $613.67, indicating a potential upside of 29.75%. Given AngioDynamics' higher probable upside, equities research analysts plainly believe AngioDynamics is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92

AngioDynamics has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Summary

Thermo Fisher Scientific beats AngioDynamics on 14 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to West Pharmaceutical Services?

AngioDynamics (NASDAQ:ANGO) and West Pharmaceutical Services (NYSE:WST) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

AngioDynamics presently has a consensus target price of $18.67, suggesting a potential upside of 56.34%. West Pharmaceutical Services has a consensus target price of $331.91, suggesting a potential upside of 5.49%. Given AngioDynamics' higher probable upside, research analysts plainly believe AngioDynamics is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.93

89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 6.0% of AngioDynamics shares are held by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

West Pharmaceutical Services has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$292.50M	1.69	-$33.99M	-$0.75	N/A
West Pharmaceutical Services	$3.07B	7.23	$493.70M	$7.48	42.06

AngioDynamics has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market.

In the previous week, West Pharmaceutical Services had 16 more articles in the media than AngioDynamics. MarketBeat recorded 16 mentions for West Pharmaceutical Services and 0 mentions for AngioDynamics. West Pharmaceutical Services' average media sentiment score of 1.14 beat AngioDynamics' score of 0.00 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Overall Sentiment
AngioDynamics	Neutral
West Pharmaceutical Services	Positive

West Pharmaceutical Services has a net margin of 16.85% compared to AngioDynamics' net margin of -10.01%. West Pharmaceutical Services' return on equity of 19.03% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-10.01%	-4.66%	-3.08%
West Pharmaceutical Services	16.85%	19.03%	14.06%

Summary

West Pharmaceutical Services beats AngioDynamics on 15 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to Smartstop Self Storage REIT?

Smartstop Self Storage REIT (NYSE:SMA) and AngioDynamics (NASDAQ:ANGO) are both small-cap health care equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, Smartstop Self Storage REIT had 6 more articles in the media than AngioDynamics. MarketBeat recorded 6 mentions for Smartstop Self Storage REIT and 0 mentions for AngioDynamics. Smartstop Self Storage REIT's average media sentiment score of 0.16 beat AngioDynamics' score of 0.00 indicating that Smartstop Self Storage REIT is being referred to more favorably in the media.

Company	Overall Sentiment
Smartstop Self Storage REIT	Neutral
AngioDynamics	Neutral

Smartstop Self Storage REIT has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smartstop Self Storage REIT	$294.00M	5.83	-$1.55M	$0.15	206.23
AngioDynamics	$292.50M	1.69	-$33.99M	-$0.75	N/A

Smartstop Self Storage REIT presently has a consensus price target of $37.17, indicating a potential upside of 20.14%. AngioDynamics has a consensus price target of $18.67, indicating a potential upside of 56.34%. Given AngioDynamics' higher possible upside, analysts clearly believe AngioDynamics is more favorable than Smartstop Self Storage REIT.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smartstop Self Storage REIT	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.73
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

89.4% of AngioDynamics shares are held by institutional investors. 5.5% of Smartstop Self Storage REIT shares are held by insiders. Comparatively, 6.0% of AngioDynamics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Smartstop Self Storage REIT has a net margin of 4.38% compared to AngioDynamics' net margin of -10.01%. Smartstop Self Storage REIT's return on equity of 1.00% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smartstop Self Storage REIT	4.38%	1.00%	0.54%
AngioDynamics	-10.01%	-4.66%	-3.08%

Smartstop Self Storage REIT has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market.

Summary

Smartstop Self Storage REIT beats AngioDynamics on 14 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to AtriCure?

AngioDynamics (NASDAQ:ANGO) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

AtriCure has higher revenue and earnings than AngioDynamics. AtriCure is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$292.50M	1.69	-$33.99M	-$0.75	N/A
AtriCure	$534.53M	2.57	-$11.45M	-$0.10	N/A

AngioDynamics presently has a consensus price target of $18.67, indicating a potential upside of 56.34%. AtriCure has a consensus price target of $48.71, indicating a potential upside of 79.76%. Given AtriCure's stronger consensus rating and higher probable upside, analysts plainly believe AtriCure is more favorable than AngioDynamics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
AtriCure	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.82

89.4% of AngioDynamics shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 6.0% of AngioDynamics shares are owned by company insiders. Comparatively, 4.0% of AtriCure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

AngioDynamics has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market. Comparatively, AtriCure has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

AtriCure has a net margin of -0.83% compared to AngioDynamics' net margin of -10.01%. AtriCure's return on equity of 0.29% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-10.01%	-4.66%	-3.08%
AtriCure	-0.83%	0.29%	0.22%

In the previous week, AtriCure had 1 more articles in the media than AngioDynamics. MarketBeat recorded 1 mentions for AtriCure and 0 mentions for AngioDynamics. AtriCure's average media sentiment score of 1.59 beat AngioDynamics' score of 0.00 indicating that AtriCure is being referred to more favorably in the news media.

Company	Overall Sentiment
AngioDynamics	Neutral
AtriCure	Very Positive

Summary

AtriCure beats AngioDynamics on 15 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to Alphatec?

Alphatec (NASDAQ:ATEC) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

Alphatec has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

AngioDynamics has lower revenue, but higher earnings than Alphatec. AngioDynamics is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alphatec	$787.08M	1.56	-$143.36M	-$0.82	N/A
AngioDynamics	$292.50M	1.69	-$33.99M	-$0.75	N/A

In the previous week, Alphatec had 3 more articles in the media than AngioDynamics. MarketBeat recorded 3 mentions for Alphatec and 0 mentions for AngioDynamics. Alphatec's average media sentiment score of 0.70 beat AngioDynamics' score of 0.00 indicating that Alphatec is being referred to more favorably in the media.

Company	Overall Sentiment
Alphatec	Positive
AngioDynamics	Neutral

AngioDynamics has a net margin of -10.01% compared to Alphatec's net margin of -15.93%. AngioDynamics' return on equity of -4.66% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alphatec	-15.93%	-1,183.84%	-15.83%
AngioDynamics	-10.01%	-4.66%	-3.08%

Alphatec presently has a consensus target price of $18.58, indicating a potential upside of 132.29%. AngioDynamics has a consensus target price of $18.67, indicating a potential upside of 56.34%. Given Alphatec's stronger consensus rating and higher possible upside, research analysts clearly believe Alphatec is more favorable than AngioDynamics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

66.3% of Alphatec shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 13.5% of Alphatec shares are held by company insiders. Comparatively, 6.0% of AngioDynamics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Alphatec beats AngioDynamics on 9 of the 17 factors compared between the two stocks.

Get AngioDynamics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ANGO vs. The Competition

Export

Metric	AngioDynamics	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$497.07M	$7.32B	$6.47B	$12.46B
Dividend Yield	N/A	1.20%	2.67%	5.34%
P/E Ratio	-15.92	45.87	23.69	23.63
Price / Sales	1.69	74.35	520.34	114.17
Price / Cash	24.70	24.88	42.35	57.17
Price / Book	2.65	7.04	9.73	6.37
Net Income	-$33.99M	$159.22M	$3.56B	$337.36M
7 Day Performance	4.01%	-2.43%	-2.92%	-2.38%
1 Month Performance	8.05%	3.34%	-0.85%	-0.57%
1 Year Performance	7.96%	-0.35%	22.23%	25.53%

AngioDynamics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ANGO AngioDynamics	3.0859 of 5 stars	$11.94 -0.7%	$18.67 +56.3%	+8.9%	$497.07M	$292.50M	N/A	760
TMO Thermo Fisher Scientific	4.9056 of 5 stars	$448.55 +0.1%	$616.10 +37.4%	+18.9%	$166.59B	$44.56B	24.66	125,000	Positive News Analyst Forecast
WST West Pharmaceutical Services	4.3034 of 5 stars	$316.86 +0.1%	$322.89 +1.9%	+44.0%	$22.35B	$3.07B	42.36	10,800	Positive News Analyst Forecast
SMA Smartstop Self Storage REIT	4.2235 of 5 stars	$30.95 -0.1%	$36.94 +19.4%	-15.8%	$1.72B	$281.14M	206.33	N/A	Dividend Cut
ATRC AtriCure	3.7293 of 5 stars	$28.29 flat	$48.71 +72.2%	-22.3%	$1.43B	$534.53M	N/A	1,300	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ANGO) was last updated on 6/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AngioDynamics (ANGO) Competitors

ANGO vs. TMO, WST, SMA, ATRC, and ATEC

How does AngioDynamics compare to Thermo Fisher Scientific?

Summary

How does AngioDynamics compare to West Pharmaceutical Services?

Summary

How does AngioDynamics compare to Smartstop Self Storage REIT?

Summary

How does AngioDynamics compare to AtriCure?

Summary

How does AngioDynamics compare to Alphatec?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO vs. The Competition

AngioDynamics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AngioDynamics (ANGO) Competitors

ANGO vs. TMO, WST, SMA, ATRC, and ATEC

How does AngioDynamics compare to Thermo Fisher Scientific?

Do insiders and institutionals believe in ANGO or TMO?

Which has better valuation and earnings, ANGO or TMO?

Is ANGO or TMO more profitable?

Does the media prefer ANGO or TMO?

Do analysts prefer ANGO or TMO?

Which has more risk & volatility, ANGO or TMO?

Summary

How does AngioDynamics compare to West Pharmaceutical Services?

Do analysts rate ANGO or WST?

Do insiders & institutionals hold more shares of ANGO or WST?

Which has higher earnings and valuation, ANGO or WST?

Which has more risk & volatility, ANGO or WST?

Does the media prefer ANGO or WST?

Is ANGO or WST more profitable?

Summary

How does AngioDynamics compare to Smartstop Self Storage REIT?

Does the media favor SMA or ANGO?

Which has better valuation and earnings, SMA or ANGO?

Do analysts recommend SMA or ANGO?

Do insiders & institutionals hold more shares of SMA or ANGO?

Is SMA or ANGO more profitable?

Which has more risk & volatility, SMA or ANGO?

Summary

How does AngioDynamics compare to AtriCure?

Which has better valuation and earnings, ANGO or ATRC?

Do analysts prefer ANGO or ATRC?

Do institutionals & insiders have more ownership in ANGO or ATRC?

Which has more volatility & risk, ANGO or ATRC?

Is ANGO or ATRC more profitable?

Does the media refer more to ANGO or ATRC?

Summary

How does AngioDynamics compare to Alphatec?

Which has more risk and volatility, ATEC or ANGO?

Which has stronger valuation and earnings, ATEC or ANGO?

Does the media favor ATEC or ANGO?

Is ATEC or ANGO more profitable?

Do analysts prefer ATEC or ANGO?

Do insiders & institutionals hold more shares of ATEC or ANGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO vs. The Competition

AngioDynamics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools